Next, we examined whether rs2853669 and the TERT promoter mutation combination influenced the risk of HCC recurrence in two independent Korean HCC patient cohorts (n = 93 for the SMH cohort; n = 72 for the KU cohort). The gene discussed is TERT; the disease is hepatocellular carcinoma.